Pacira BioSciences, Inc. Financial Ratios — PCRX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-48.13	-46.36	-45.35	-5.53	0.52	-9.74	-8.36	-0.07	-1.45	13.82	2.51	0.85	2.58	-6.37	0.5
Return on Capital (%)	- -	- -	- -	- -	-3.93	- -	- -	- -	- -	- -	10.56	- -	9.82	- -	4.03
Return on Invested Capital (%)	- -	- -	- -	- -	2.77	- -	- -	- -	- -	- -	4.43	- -	3.98	- -	0.63
Gross Margin (%)	-6.69	17.77	35.98	60.82	71.15	60.16	69.33	74.25	74.65	72.69	74.1	70.11	72.64	75.69	79.39
EBITDA Margin (%)	-202.49	-111.68	-55.57	2.46	8.41	-6.91	-3.87	8.62	7.14	15.42	21.88	22.72	24.19	24.06	15.17
Operating Margin (%)	-229.98	-126.13	-62.29	-2.61	3.8	-11.59	-8.7	4.72	2.49	10.79	16.61	9	12.99	12.82	2.64
Incremental Operating Margin (%)	- -	- -	- -	- -	28.48	- -	- -	80.66	-6.49	416.08	38.94	-23.86	339.07	8.45	-277.78
Pretax Margin (%)	-276.17	-133.77	-75.22	-6.85	0.85	-13.69	-14.82	-0.13	-2.55	4.68	10.42	1.99	9.14	-9	2.32
Profit Margin (%)	-276.17	-133.77	-74.7	-6.94	0.75	-13.73	-14.87	-0.14	-2.62	33.87	7.75	2.39	6.22	-14.2	0.97
Net Income to Common Margin (%)	-276.17	-133.77	-74.7	-6.94	0.75	-13.73	-14.87	-0.14	-2.62	33.87	7.75	2.39	6.22	-14.2	0.97
Effective Tax Rate (%)	- -	- -	- -	- -	12.45	- -	- -	- -	- -	- -	25.57	- -	32	- -	58.31
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	26	25	99	103	104	109	276	291	352	541	1,129	763	586	639	418
ST Debt	7	- -	99	103	104	- -	- -	- -	5	157	383	43	17	211	10
LT Debt	19	25	- -	- -	- -	109	276	291	347	384	746	721	569	428	408
Total Debt/EBITDA	-0.81	-0.58	-2.08	21.17	4.97	-5.69	-24.9	10	11.71	8.17	9.53	5.04	3.59	3.79	3.79
Net Debt/EBITDA	0.65	-0.35	-1.82	13.47	2.25	-3.81	-20.03	5.45	7.58	5.47	3.91	3.86	2.26	1.83	1.94
Total Debt/EBIT	-0.71	-0.51	-1.86	-19.96	11	-3.4	-11.09	18.28	33.58	11.67	12.55	12.72	6.68	7.11	21.79
Net Debt/EBIT	0.57	-0.31	-1.62	-12.7	4.98	-2.27	-8.92	9.95	21.74	7.83	5.16	9.75	4.21	3.43	11.13
EBITDA to Interest Expense	-6.65	-24.16	-7.14	0.64	2.94	-2.96	-0.67	1.43	1.37	2.82	4.09	4.26	9.43	12.55	7.55
EBITDA-CapEx/Interest Expense	-7.94	-34.26	-8.97	-2.37	-2.72	-6.79	-1.82	0.72	0.91	1.21	2.5	3.41	8.56	11.76	6.5
EBIT to Interest Expense	-7.55	-27.28	-8	-0.67	1.33	-4.97	-1.5	0.78	0.48	1.97	3.1	1.69	5.06	6.69	1.31
Interest Expense	5	2	7	8	7	6	17	20	22	24	29	36	17	13	15
Common Equity/Total Assets	-158.79	-207.48	-174.53	-95.1	-79.5	-88.44	-61.92	-56.31	-48.05	-19.92	-10.21	-8.85	-6.78	-13.28	-15.75
Long-Term Debt/Equity (%)	38.4	38.25	- -	- -	- -	49.66	98.82	90.46	97.76	61.98	102.17	92.98	65.35	55.01	58.92
Long-Term Debt/Capital (%)	-11.99	-12.15	- -	- -	- -	-45.79	-245.27	-298.79	-731.45	133.68	81.38	117.23	118.63	98.99	186.53
Long-Term Debt/Total Assets (%)	16.33	22.48	- -	- -	- -	27.78	43.95	42.15	41.75	30.13	35.96	42.86	36.12	27.56	32.28
Total Debt/Equity (%)	52.99	38.25	239.91	60.24	47.64	49.66	98.93	90.57	99.15	87.32	154.55	98.5	67.35	82.08	60.34
Total Debt/Capital (%)	-16.54	-12.15	-50.12	-49.8	-50.95	-45.79	-245.56	-299.14	-741.85	188.35	123.1	124.19	122.27	147.7	191.02
Total Debt/Total Assets (%)	22.54	22.48	58.27	31.62	26.83	27.78	44	42.2	42.35	42.46	54.39	45.41	37.22	41.12	33.06
Net Debt to Equity	-42.66	22.88	209.57	38.32	21.55	33.24	79.57	49.31	64.18	58.53	63.48	75.53	42.42	39.64	30.82
Net Debt/Capital (%)	10.25	-6.93	-41.17	-26.82	-18.02	-26.62	-133.38	-68.94	-181.29	193.62	139.9	114.65	113.23	198.08	353.8
EBITDA	-32	-44	-48	5	21	-19	-11	29	30	66	118	152	163	169	110
EBITDA-CapEx	-38	-62	-60	-18	-19	-44	-30	15	20	28	73	121	148	158	95
Operating Income (Loss)	-36	-49	-53	-5	9	-32	-25	16	10	46	90	60	88	90	19

Liquidity (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.39	2.9	0.59	1.12	1.06	3.85	5.54	6.32	2.71	2.06	1.26	1.95	2.86	1.56	1.98
Current Ratio	2.59	4.3	0.88	1.53	1.69	5.42	6.96	7.88	3.79	2.57	1.66	3.37	5.24	2.4	4.54
Quick Ratio	2.45	3.21	0.71	1.28	1.23	4.52	6.1	6.95	3.15	2.27	1.44	2.62	3.94	1.93	3.01
CFO/Avg Current Liab	-1.29	-3.04	-0.64	0.2	0.19	0.34	0.35	0.84	0.84	0.43	0.32	0.43	1.26	0.93	0.71
Common Equity/Total Assets	-158.79	-207.48	-174.53	-95.1	-79.5	-88.44	-61.92	-56.31	-48.05	-19.92	-10.21	-8.85	-6.78	-13.28	-15.75
Long-Term Debt/Equity (%)	38.4	38.25	- -	- -	- -	49.66	98.82	90.46	97.76	61.98	102.17	92.98	65.35	55.01	58.92
Long-Term Debt/Capital (%)	-11.99	-12.15	- -	- -	- -	-45.79	-245.27	-298.79	-731.45	133.68	81.38	117.23	118.63	98.99	186.53
Long-Term Debt/Total Assets (%)	16.33	22.48	- -	- -	- -	27.78	43.95	42.15	41.75	30.13	35.96	42.86	36.12	27.56	32.28
Total Debt/Equity (%)	52.99	38.25	239.91	60.24	47.64	49.66	98.93	90.57	99.15	87.32	154.55	98.5	67.35	82.08	60.34
Total Debt/Capital (%)	-16.54	-12.15	-50.12	-49.8	-50.95	-45.79	-245.56	-299.14	-741.85	188.35	123.1	124.19	122.27	147.7	191.02
Total Debt/Total Assets (%)	22.54	22.48	58.27	31.62	26.83	27.78	44	42.2	42.35	42.46	54.39	45.41	37.22	41.12	33.06
CFO/Total Liabilities	-47.53	-151.8	-34.1	17.15	16.55	19.39	5.1	13.28	14.81	11.76	9.35	16.03	21.96	24.43	26.58
CFO/CapEx	-5.03	-3.84	-3.6	1.16	0.7	1.35	0.92	3.37	6.94	2.04	2.74	4.83	10.2	17.81	9.91
Altman's Z-Score	-1.42	2.97	5.6	11.58	9.86	3.96	3.23	3.42	2.78	2.99	1.92	2.27	2.74	1.77	2.38

Working Capital (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	9.5	12.09	9.03	10.7	10.33	9.91	9.31	9.68	9.85	8.54	7.25	6.85	6.62	6.41	6.12
Days Sales Outstanding	38.43	30.19	40.41	34.12	35.34	36.84	39.22	37.69	37.07	42.72	50.34	53.29	55.14	56.98	59.64
Inventory Turnover	11.75	4.82	3.96	3.46	1.58	2.37	2.42	1.93	2	1.91	1.72	2.05	1.84	1.48	1.08
Days Inventory Outstanding	31.07	75.65	92.08	105.63	230.95	154.02	150.89	189.09	182.76	191.24	212.36	178.21	198.06	245.9	338.98
Accounts Payable Turnover	3.46	14.3	20.66	18.55	13.45	9.81	8.85	6.48	8.57	10.65	16.61	15.28	12.48	10.99	10.35
Accounts Payable Turnover Days	105.61	25.52	17.66	19.68	27.14	37.19	41.26	56.35	42.58	34.28	21.98	23.89	29.24	33.22	35.28
Cash Conversion Cycle	-36.1	80.32	114.82	120.07	239.16	153.67	148.85	170.43	177.26	199.68	240.71	207.61	223.96	269.66	363.33
Inventory to Cash Days	7.36	-45.46	-51.67	-71.51	-195.61	-117.18	-111.67	-151.4	-145.69	-148.52	-162.02	-124.92	-142.92	-188.92	-279.34
Inventories	1	12	16	29	62	31	41	49	58	65	99	96	104	125	153
Raw Materials	1	4	5	9	17	12	16	19	20	27	36	40	54	51	43
Work In Process	- -	6	6	9	12	12	8	10	14	16	35	29	31	27	28
Finished Goods	- -	2	4	11	33	8	17	20	24	21	27	27	19	47	81
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	142	530	1,908	3,130	2,806	1,203	1,817	1,760	1,881	2,553	2,663	1,758	1,560	871	1,153
- Cash & Cash Equivalents	46	10	13	38	57	36	54	133	78	100	586	104	153	277	159
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	26	25	99	103	104	109	276	291	352	541	1,129	763	586	639	418
Enterprise Value	92	514	1,934	3,076	2,751	1,139	1,782	1,667	1,941	2,573	3,136	2,232	1,867	1,025	1,333
Total Capital	-155	-207	-197	-207	-204	-237	-113	-97	-47	287	917	615	479	433	219
Total Debt/Capital (%)	-16.54	-12.15	-50.12	-49.8	-50.95	-45.79	-245.56	-299.14	-741.85	188.35	123.1	124.19	122.27	147.7	191.02
Total Debt / EV	0.28	0.05	0.05	0.03	0.04	0.1	0.16	0.17	0.18	0.21	0.36	0.34	0.31	0.62	0.31
EV/Sales	5.84	13.15	22.61	15.56	11.05	4.12	6.22	4.94	4.61	5.99	5.79	3.35	2.77	1.46	1.84
EV/EBITDA	- -	- -	- -	631.63	131.44	- -	- -	57.34	64.56	38.83	26.47	14.73	11.44	6.08	12.1
EV/EBIT	- -	- -	- -	- -	290.96	- -	- -	104.77	185.16	55.51	34.87	37.19	21.29	11.41	69.47
EV/Cash Flow to Firm	- -	- -	- -	89.63	80.33	28.53	51.65	23.36	20.87	10.4	21.29	11.89	11.22	4.87	8.43
EV/Free Cash Flow to Firm	- -	- -	- -	53.68	36.91	17.62	33.15	19.41	18.81	9.02	16.23	10.24	10.28	4.64	7.69
Diluted Market Cap	142	530	1,908	3,130	3,172	1,203	1,817	1,760	1,881	2,614	2,746	1,797	1,754	871	1,166
Diluted Enterprise Value	122	545	1,994	3,195	3,219	1,276	2,040	1,918	2,154	3,055	3,289	2,456	2,187	1,233	1,425
EV per Share	5.57	16.95	58.3	87.14	75.29	30.59	44.77	40.76	46.74	60.3	70.84	49.04	40.39	22.18	29.91
TTM Sales	16	39	86	198	249	276	287	337	421	430	542	667	675	701	726
TTM EBITDA	-32	-44	-48	5	21	-19	-11	29	30	66	118	152	163	169	110
TTM Operating Income	-36	-49	-53	-5	9	-32	-25	16	10	46	90	60	88	90	19
TTM Cash Flow to Firm	-26	-68	-37	34	34	40	35	71	93	247	147	188	166	211	158
TTM Free Cash Flow to Firm	-20	-50	-25	57	75	65	54	86	103	285	193	218	182	221	173

Multiples (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-5.73	-10.22	-60.24	63.16	46.42	20.68	49.04	27.77	23.31	22.76	16	10.25	10.33	4.36	6.97
EV/EBIT	- -	- -	- -	- -	290.96	- -	- -	104.77	185.16	55.51	34.87	37.19	21.29	11.41	69.47
Enterprise Value	92	514	1,934	3,076	2,751	1,139	1,782	1,667	1,941	2,573	3,136	2,232	1,867	1,025	1,333
Low Price	6.16	7.38	17.15	54.23	35.78	29.95	29.81	26.95	34.64	27.46	45.05	37.69	25.93	11.16	18.17
EV/Sales	5.84	13.15	22.61	15.56	11.05	4.12	6.22	4.94	4.61	5.99	5.79	3.35	2.77	1.46	1.84
EV/EBITDA	- -	- -	- -	631.63	131.44	- -	- -	57.34	64.56	38.83	26.47	14.73	11.44	6.08	12.1
Price/Earnings	- -	- -	- -	- -	1,511.8	- -	- -	- -	- -	17.55	63.44	110.48	37.17	- -	163.97
Price/Earnings Average	-3.5	-7.99	-18.31	-216.77	1,460.51	-44.09	-39.58	-3,476.43	-154.45	14.69	65.11	168.92	40.3	-10.85	154.42
Price/Earnings High	-5.82	-11.2	-30.23	-288.23	2,400.89	-75.31	-55.07	-4,777.29	-186.54	19.96	84.35	235.09	53.54	-16.7	175.12
Price/Earnings Low	-2.34	-4.28	-8.9	-139.56	704.42	-29.39	-27.85	-2,340.87	-130.54	8.05	47.5	107.84	28.57	-5.18	115.12
Price/Book Value	-0.79	-2.28	-6.44	-10.09	-9.1	-3.47	-4.67	-4.53	-4.71	-10.06	-12.57	-11.82	-14.61	-4.22	-5.79
Price/Book Value Average	-0.84	-1.8	-3.95	-9.59	-8.79	-4.83	-4.33	-4.22	-4.26	-8.42	-12.9	-18.07	-15.84	-5.23	-5.45
Price/Book Value High	-1.4	-2.52	-6.52	-12.75	-14.46	-8.25	-6.03	-5.8	-5.15	-11.44	-16.71	-25.15	-21.04	-8.06	-6.18
Price/Book Value Low	-0.56	-0.96	-1.92	-6.17	-4.24	-3.22	-3.05	-2.84	-3.6	-4.62	-9.41	-11.54	-11.23	-2.5	-4.06
Price/Tangible Book Value	3.31	9.75	64.09	21.29	14.97	6.98	8.1	6.79	12.45	6.03	-68.76	24.68	6.97	2.47	3.78
Price/Tangible Book Value Average	3.52	7.68	39.32	20.23	14.46	9.71	7.52	6.32	11.27	5.05	-70.57	37.73	7.56	3.06	3.56
Price/Tangible Book Value High	5.86	10.78	64.91	26.9	23.77	16.59	10.46	8.68	13.61	6.86	-91.41	52.51	10.05	4.72	4.04
Price/Tangible Book Value Low	2.35	4.12	19.11	13.02	6.98	6.47	5.29	4.25	9.52	2.77	-51.48	24.09	5.36	1.46	2.66
Price/Sales	9.06	13.56	22.3	15.83	11.27	4.35	6.34	5.22	4.47	5.94	4.92	2.64	2.31	1.24	1.59
Price/Sales Average	9.65	10.68	13.68	15.04	10.89	6.05	5.88	4.85	4.04	4.98	5.05	4.03	2.5	1.54	1.5
Price/Sales High	16.07	14.99	22.58	20	17.9	10.34	8.19	6.67	4.88	6.76	6.54	5.61	3.33	2.37	1.7
Price/Sales Low	6.45	5.73	6.65	9.68	5.25	4.04	4.14	3.27	3.42	2.73	3.68	2.57	1.78	0.74	1.11
Price/Cash Flow	-4.59	-7.56	-43.52	117.81	100.14	35.95	102.17	36.01	26.67	33.15	21.18	12.1	10.08	4.6	7.59
Price/Cash Flow Average	-4.89	-5.95	-26.69	111.93	96.74	50.01	94.83	33.51	24.13	27.75	21.74	18.5	10.93	5.7	7.15
Price/Cash Flow High	-8.13	-8.35	-44.07	148.82	159.03	85.43	131.94	46.04	29.14	37.71	28.17	25.74	14.53	8.78	8.1
Price/Cash Flow Low	-3.27	-3.19	-12.98	72.06	46.66	33.34	66.72	22.56	20.39	15.21	15.86	11.81	7.75	2.73	5.33
Price/Free Cash Flow Average	-6.1	-8.05	-36.95	60.01	44.85	28.77	45.52	25.83	21.09	19.06	16.42	15.67	11.2	5.4	6.56
Price/Free Cash Flow High	-10.15	-11.29	-61.01	79.79	73.73	49.14	63.33	35.5	25.47	25.9	21.27	21.81	14.88	8.31	7.44
Price/Free Cash Flow Low	-4.08	-4.32	-17.97	38.63	21.63	19.17	32.03	17.39	17.82	10.45	11.98	10	7.94	2.58	4.89
EV/Sales Average	8.34	11.07	14.69	15.37	11.08	6.32	6.66	5.32	4.69	6	6.05	5.02	3.15	2.06	1.85
EV/Sales High	14.76	15.37	23.59	20.33	18.08	10.6	8.96	7.14	5.53	7.79	7.54	6.6	3.97	2.89	2.05
EV/Sales Low	5.14	6.11	7.66	10.02	5.44	4.3	4.92	3.74	4.07	3.75	4.69	3.56	2.42	1.25	1.47
EV/EBITDA Average	-4.12	-9.91	-26.43	623.99	131.76	-91.38	-171.92	61.75	65.71	38.92	27.66	22.09	13.01	8.55	12.21
EV/EBITDA High	-7.29	-13.76	-42.45	825.25	215.15	-153.4	-231.35	82.82	77.47	50.5	34.47	29.03	16.41	12	13.53
EV/EBITDA Low	-2.54	-5.47	-13.79	406.54	64.71	-62.18	-126.89	43.36	56.95	24.34	21.42	15.67	9.99	5.21	9.7
EV/EBIT Average	-3.63	-8.78	-23.58	-588.35	291.67	-54.52	-76.55	112.84	188.46	55.64	36.44	55.76	24.22	16.05	70.13
EV/EBIT High	-6.42	-12.19	-37.87	-778.11	476.27	-91.51	-103.02	151.34	222.19	72.19	45.42	73.29	30.56	22.53	77.72
EV/EBIT Low	-2.24	-4.85	-12.3	-383.32	143.25	-37.1	-56.5	79.23	163.33	34.8	28.22	39.57	18.61	9.77	55.73
Last Price	8.65	17.47	57.49	88.66	76.79	32.3	45.65	43.02	45.3	59.84	60.17	38.61	33.74	18.84	25.88
High Price	15.34	19.31	58.22	112	121.95	76.75	58.95	55	49.5	68.08	80	82.16	48.6	35.95	27.64
Enterprise Value Average	131	433	1,257	3,039	2,758	1,746	1,909	1,796	1,975	2,579	3,277	3,347	2,123	1,442	1,346
Enterprise Value High	232	601	2,018	4,019	4,503	2,931	2,569	2,409	2,329	3,346	4,084	4,399	2,679	2,025	1,491
Enterprise Value Low	81	239	655	1,980	1,354	1,188	1,409	1,261	1,712	1,613	2,537	2,375	1,631	878	1,069

Shares Outstanding	25	33	34	36	37	37	41	41	42	44	45	46	46	46	41
Diluted Weighted Avg Shares	16	30	33	35	41	37	40	41	42	44	46	47	52	46	45
Basic Weighted Avg Shares	16	30	33	35	37	37	40	41	42	43	44	46	46	46	45
Revenue per Share	0.95	1.29	2.58	5.6	6.81	7.42	7.2	8.24	10.14	10.07	12.23	14.65	14.6	15.16	16.3
EBITDA per Share	-1.93	-1.44	-1.43	0.14	0.57	-0.51	-0.28	0.71	0.72	1.55	2.68	3.33	3.53	3.65	2.47
Operating Income per Share	-2.2	-1.63	-1.61	-0.15	0.26	-0.86	-0.63	0.39	0.25	1.09	2.03	1.32	1.9	1.94	0.43
Basic EPS, GAAP	-2.64	-1.72	-1.93	-0.39	0.05	-1.02	-1.07	-0.01	-0.27	3.41	0.95	0.35	0.91	-2.15	0.16
Basic EPS from Cont Ops	-2.64	-1.72	-1.93	-0.39	0.05	-1.02	-1.07	-0.01	-0.27	3.41	0.95	0.35	0.91	-2.15	0.16
Diluted EPS, GAAP	-2.64	-1.72	-1.93	-0.39	0.04	-1.02	-1.07	-0.01	-0.27	3.33	0.92	0.34	0.81	-2.15	0.16
Diluted EPS from Cont Ops	-2.64	-1.72	-1.93	-0.39	0.04	-1.02	-1.07	-0.01	-0.27	3.33	0.92	0.34	0.81	-2.15	0.16
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.89	-2.31	-1.32	0.75	0.77	0.9	0.45	1.19	1.7	1.81	2.84	3.19	3.35	4.1	3.41
Free Cash Flow per Basic Share	-2.26	-2.91	-1.69	0.1	-0.34	0.23	-0.04	0.84	1.45	0.92	1.8	2.53	3.02	3.87	3.07
Cash & Equivalents per Share	4.63	1.35	2.17	4.44	4.35	4.64	7.82	9.37	7.03	12.23	14.83	6.34	6.03	10.48	5.35
Book Value per Share	-10.96	-7.66	-8.93	-8.79	-8.44	-9.3	-9.77	-9.49	-9.62	-5.95	-4.79	-3.27	-2.31	-4.46	-4.47
Tangible Book Value per Share	2.62	1.79	0.9	4.16	5.13	4.63	5.63	6.34	3.64	9.93	-0.88	1.56	4.84	7.62	6.84

Pacira BioSciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)